Last reviewed · How we verify

NCT06836804: TURK-CDS

Validity and Reliability of the Turkish Version of the Cardiac Depression Scale

Completed Last updated 14 April 2026
What this trial tests

trial testing Sociodemographic Data Form in Cardiovascular Diseases in 360 participants. Completed in 1 January 2026.

Timeline
11 February 2025
Primary endpoint
1 November 2025
1 January 2026

Quick facts

Lead sponsorKırıkkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment360
Start date11 February 2025
Primary completion1 November 2025
Estimated completion1 January 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kırıkkale University

Who can join

18 and older, any sex, with Cardiovascular Diseases or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Cardiac Depression Scale (CDS) in both its long and short forms has been validated in various languages and populations and is used to detect depression in individuals with cardiovascular disease (CVD). However, there is no validity and reliability study of the CDS for CVD patients in the Turkish population available in the literature, which prevents its use in Turkish population. The study aims to test the validity and reliability of the Turkish version of long and short forms of the CDS in Turkish individuals with CVD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Kırıkkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06836804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing